Prof Martin Birchall is UCL's Professor of Laryngology and a Consultant in ENT Surgery at the Royal National Throat Nose and Ear Hospital. He is one the leading academic Otolaryngologists in the world as measured by the impact of his papers. A specialist in disorders of voice, swallowing and breathing, he has pioneered the use stem cells and tissue engineering in surgery.Clinically, he has a particular interest in voice, swallowing and pharyngeal pouches, airway disorders such as stenosis, cough and neck lumps. He is part of multidisciplinary voice and airway teams and established with Mr. Guri Sandhu, Mr Khalid Ghuffoor and respiratory, thoracic surgery, anaesthetic and other colleagues a national referral team for complex airway disorders. He treats patients with vocal cord weakness ('palsy'), and is trialling a new means of restoring function for them using the drive from unaffected nerves. In a monthly intervention clinic, run with top speech and language therapists, He uses the latest technology, such as transnasal oesophagoscopy and transcutaneous vocal cord injection, to treat voice and swallowing problems. He has a large research group concentrating on the use of innovative technology to manage disorders of the airways, especially the use of tissue engineering, stem cells and information technology. In 2008, he co-led the team which performed the world's first stem cell based organ transplant, and with Prof Elliott at Great Ormond St, co-led the team which performed the same feat in a child in 2010. In 2010 he was also part of the team which performed the world's second (and first functionally reinnervated) laryngeal transplant at UC Davis, California. He was Morgan Stanley Briton of the Year (Science and Technology), 2008, and is a frequent guest speaker at major international conferences. He has published in the Lancet, Nature and the BMJ. With Guri Sandhu and David howard, he founded the British Laryngological Association in 2011, and runs a successful annual conference 'Cutting Edge Laryngology'.
Markus Hess, MD, is a dedicated otolaryngologist and phoniatrician (speech-language pathology and medicine), subspecializing in laryngology, phonosurgery, and disorders of professional voice users. He is co-founder and Head of the first Voice Clinic in Germany (Deutsche Stimmklinik, 2014).He accepted 1998 a position as full professor at the University Medical Center Hamburg-Eppendorf and Professor of Phoniatrics. Dr. Hess graduated from University Medical School, Düsseldorf, and Freie Universität, Berlin, and is a fellowship trained, board-certified Otolaryngologist and board-certified Phoniatrist. He trained as a HEISENBERG PhD fellow from the German Research Council (DFG) at HARVARD medical school and lectured thereafter for many years as active member and visiting lecturer within the HARVARD - M.I.T. health science and technology program. He is a leading physician-scientist in the area of research of basic voice physiology, vocal fold vibration analysis and voice disorders. He now specializes in the care of the performing voice and the treatment of voice disorders. Dr. Hess has long-standing experience in performing the full spectrum of endoscopic and open surgical procedures on the larynx. He has invented many improvements for diagnostics and operative techniques in laryngology and holds a patent on LED-stroboscopy. Dr. Hess brings a multidisciplinary approach to such patients as public speakers, singers, and actors. His surgical patients receive cutting-edge minimally invasive techniques in laryngeal microsurgery as well as office-based voice surgery in topical anesthesia. Dr. Hess has authored or co-authored over hundred peer-reviewed articles in professional journals, book chapters, and textbooks. He is Secretary General of Pan European Conferences (PEVOC) since 2003, a founding member of the 'German Society of Phonosurgery', founder and Executive Board member of the European Academy of Voice (EAV), incoming President of the international Collegium Medicorum Theatri (CoMeT) and serves in multiple capacities on many international editorial and scientific boards and committees. Dr. Hess teaches regularly at national and international voice conferences and gives own courses in cutting-edge phonosurgery techniques.
Dr. Lui obtained her Ph.D. (Hons) training in Molecular Pharmacology at the University of Pittsburgh School of Medicine, USA, followed by post-doctoral trainings at Duke University and University of Pittsburgh, USA. Dr. Lui is devoted to the development of precision medicine for treatment of the upper aerodigestive tract cancers, including head and neck cancers, and nasopharyngeal cancer. Using genomics, proteomics, integrative genomic-proteomic discovery, and a driver mutation screening platform (US patented; co-Inventor), Dr. Lui has contributed to major mutationally-driven drug sensitivity findings in head and neck cancer. As a trained biochemist, Dr. Lui also investigates into the signaling mechanisms selected by mutational events for head and neck cancer tumorigenesis and drug sensitivity. Dr. Lui has obtained research fundings from both the US and the Research Grant Council, Hong Kong, and published over 90 research articles (H-Index=30) in the area of precision medicine, cancer genomics and therapeutics, as well as cancer biology in international and renowned scientific Journals including Cancer Discovery, Nature Communications, JAMA Oncology, PNAS and the Journal of National Cancer Institute, etc.